OMNIAB INC (OABI) Stock Fundamental Analysis

NASDAQ:OABI • US68218J1034

1.72 USD
-0.08 (-4.44%)
At close: Feb 27, 2026
1.72 USD
0 (0%)
After Hours: 2/27/2026, 8:23:39 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

Overall OABI gets a fundamental rating of 4 out of 10. We evaluated OABI against 57 industry peers in the Life Sciences Tools & Services industry. While OABI has a great health rating, there are worries on its profitability. While showing a medium growth rate, OABI is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year OABI has reported negative net income.
  • OABI had a negative operating cash flow in the past year.
  • OABI had negative earnings in each of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: OABI reported negative operating cash flow in multiple years.
OABI Yearly Net Income VS EBIT VS OCF VS FCFOABI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

  • OABI's Return On Assets of -20.54% is on the low side compared to the rest of the industry. OABI is outperformed by 66.67% of its industry peers.
  • The Return On Equity of OABI (-22.92%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -20.54%
ROE -22.92%
ROIC N/A
ROA(3y)-12.62%
ROA(5y)-10.53%
ROE(3y)-14.73%
ROE(5y)-12.64%
ROIC(3y)N/A
ROIC(5y)N/A
OABI Yearly ROA, ROE, ROICOABI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -5 -10 -15 -20

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for OABI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OABI Yearly Profit, Operating, Gross MarginsOABI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 -50 -100 -150 -200 -250

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • OABI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for OABI has been increased compared to 1 year ago.
  • OABI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
OABI Yearly Shares OutstandingOABI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
OABI Yearly Total Debt VS Total AssetsOABI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

  • An Altman-Z score of 3.42 indicates that OABI is not in any danger for bankruptcy at the moment.
  • With a decent Altman-Z score value of 3.42, OABI is doing good in the industry, outperforming 75.44% of the companies in the same industry.
  • OABI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.42
ROIC/WACCN/A
WACC10.75%
OABI Yearly LT Debt VS Equity VS FCFOABI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • OABI has a Current Ratio of 5.00. This indicates that OABI is financially healthy and has no problem in meeting its short term obligations.
  • OABI's Current ratio of 5.00 is fine compared to the rest of the industry. OABI outperforms 77.19% of its industry peers.
  • OABI has a Quick Ratio of 4.96. This indicates that OABI is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 4.96, OABI belongs to the top of the industry, outperforming 87.72% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5
Quick Ratio 4.96
OABI Yearly Current Assets VS Current LiabilitesOABI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 6.45% over the past year.
  • OABI shows a small growth in Revenue. In the last year, the Revenue has grown by 3.36%.
  • OABI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.57% yearly.
EPS 1Y (TTM)6.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.5%
Revenue 1Y (TTM)3.36%
Revenue growth 3Y-8.76%
Revenue growth 5Y7.57%
Sales Q2Q%-46.33%

3.2 Future

  • Based on estimates for the next years, OABI will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.16% on average per year.
  • The Revenue is expected to grow by 27.23% on average over the next years. This is a very strong growth
EPS Next Y7.71%
EPS Next 2Y15.26%
EPS Next 3Y13.43%
EPS Next 5Y13.16%
Revenue Next Year-25.22%
Revenue Next 2Y11.48%
Revenue Next 3Y20.43%
Revenue Next 5Y27.23%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
OABI Yearly Revenue VS EstimatesOABI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 50M 100M 150M 200M
OABI Yearly EPS VS EstimatesOABI Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -0.2 -0.4 -0.6

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • OABI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year OABI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OABI Price Earnings VS Forward Price EarningsOABI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OABI Per share dataOABI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

  • OABI's earnings are expected to grow with 13.43% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.26%
EPS Next 3Y13.43%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • OABI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

OMNIAB INC

NASDAQ:OABI (2/27/2026, 8:23:39 PM)

After market: 1.72 0 (0%)

1.72

-0.08 (-4.44%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)11-04
Earnings (Next)03-04
Inst Owners44.27%
Inst Owner ChangeN/A
Ins Owners5.71%
Ins Owner Change2.78%
Market Cap247.61M
Revenue(TTM)21.09M
Net Income(TTM)-63.60M
Analysts84.62
Price Target7.48 (334.88%)
Short Float %5.32%
Short Ratio12.13
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.16%
Min EPS beat(2)1.96%
Max EPS beat(2)4.35%
EPS beat(4)2
Avg EPS beat(4)0.06%
Min EPS beat(4)-4.45%
Max EPS beat(4)4.35%
EPS beat(8)4
Avg EPS beat(8)0.62%
EPS beat(12)5
Avg EPS beat(12)5.36%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-44.74%
Min Revenue beat(2)-61.11%
Max Revenue beat(2)-28.38%
Revenue beat(4)1
Avg Revenue beat(4)-23.54%
Min Revenue beat(4)-61.11%
Max Revenue beat(4)4.57%
Revenue beat(8)2
Avg Revenue beat(8)-23.65%
Revenue beat(12)3
Avg Revenue beat(12)-20.86%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)6.4%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-11.11%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 11.74
P/FCF N/A
P/OCF N/A
P/B 0.89
P/tB 3.8
EV/EBITDA N/A
EPS(TTM)-0.58
EYN/A
EPS(NY)-0.4
Fwd EYN/A
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS0.15
BVpS1.93
TBVpS0.45
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -20.54%
ROE -22.92%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-12.62%
ROA(5y)-10.53%
ROE(3y)-14.73%
ROE(5y)-12.64%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2.75%
Cap/Sales 2.87%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5
Quick Ratio 4.96
Altman-Z 3.42
F-Score5
WACC10.75%
ROIC/WACCN/A
Cap/Depr(3y)36.82%
Cap/Depr(5y)29.77%
Cap/Sales(3y)13.66%
Cap/Sales(5y)12.04%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%12.5%
EPS Next Y7.71%
EPS Next 2Y15.26%
EPS Next 3Y13.43%
EPS Next 5Y13.16%
Revenue 1Y (TTM)3.36%
Revenue growth 3Y-8.76%
Revenue growth 5Y7.57%
Sales Q2Q%-46.33%
Revenue Next Year-25.22%
Revenue Next 2Y11.48%
Revenue Next 3Y20.43%
Revenue Next 5Y27.23%
EBIT growth 1Y9.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year42.17%
EBIT Next 3Y13.11%
EBIT Next 5YN/A
FCF growth 1Y-1479.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-905.12%
OCF growth 3YN/A
OCF growth 5YN/A

OMNIAB INC / OABI FAQ

What is the ChartMill fundamental rating of OMNIAB INC (OABI) stock?

ChartMill assigns a fundamental rating of 4 / 10 to OABI.


Can you provide the valuation status for OMNIAB INC?

ChartMill assigns a valuation rating of 0 / 10 to OMNIAB INC (OABI). This can be considered as Overvalued.


How profitable is OMNIAB INC (OABI) stock?

OMNIAB INC (OABI) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for OABI stock?

The Earnings per Share (EPS) of OMNIAB INC (OABI) is expected to grow by 7.71% in the next year.